Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Mersana Therapeutics, Inc. (MRSN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
SC 13G
| Venrock Healthcare Capital Partners III, L.P. reports a 8.5% stake in Mersana Therapeutics, Inc. |
| 07/27/2023 |
SC 13G
| EcoR1 Capital, LLC reports a 16.9% stake in Mersana Therapeutics, Inc. |
| 02/17/2022 |
SC 13G
| MILLENNIUM MANAGEMENT LLC reports a 5.2% stake in MERSANA THERAPEUTICS, INC. |
| 02/11/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/10/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/27/2022 |
SC 13G
| BlackRock Inc. reports a 10.4% stake in MERSANA THERAPEUTICS INC |
| 09/15/2021 |
SC 13G
| BB BIOTECH AG reports a 5.8% stake in MERSANA THERAPEUTICS, INC. |
| 02/12/2021 |
SC 13G
| Avoro Capital Advisors LLC reports a 9.9% stake in Mersana Therapeutics, Inc. |
| 02/04/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/25/2021 |
SC 13G
| Sarissa Capital Management LP reports a 5.5% stake in Mersana Therapeutics, Inc. |
| 02/07/2020 |
SC 13G
| BlackRock Inc. reports a 5.1% stake in MERSANA THERAPEUTICS INC |
| 12/20/2019 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 5.2% stake in Mersana Therapeutics, Inc. |
| 03/11/2019 |
SC 13G
| BIOTECHNOLOGY VALUE FUND L P reports a 5.2% stake in Mersana Therapeutics, Inc. |
| 03/11/2019 |
SC 13G
| Sarissa Capital Management LP reports a 7.9% stake in Mersana Therapeutics, Inc. |
| 02/14/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/09/2018 |
SC 13G
| Rho Ventures V, L.P. reports a 5.9% stake in Mersana Therapeutics, Inc. |
| 08/10/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/13/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/07/2017 |
SC 13G
| Rock Springs Capital Management LP reports a 6.8% stake in Mersana Therapeutics, Inc. |
| 07/06/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|
|